Other — Consolidated long-lived assets

Geographic · Consolidated long-lived assets

Thermo Fisher Scientific Other — Consolidated long-lived assets increased by 20.1% to $5.47B in Q4 2025 compared to the prior quarter.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2023
Last reportedQ4 2025

How to read this metric

An increase indicates significant capital investment or asset acquisition in non-core segments, whereas a decrease may signal asset impairment, depreciation, or a reduction in the scale of these operations.

Detailed definition

This metric measures the total book value of long-term, non-current assets, such as property, plant, equipment, and inta...

Peer comparison

Comparable to 'Other' or 'Unallocated' long-lived assets reported by diversified industrial or life science peers, reflecting the footprint of non-core business segments.

Metric ID: tmo_segment_other_consolidated_long_lived_assets

Historical Data

3 periods
 Q4 '23Q4 '24Q4 '25
Value$4.65B$4.55B$5.47B
QoQ Change-2.2%+20.1%
YoY Change-2.2%+20.1%
Range$4.55B$5.47B
Avg YoY Growth+9.0%
Median YoY Growth+9.0%

Frequently Asked Questions

What is Thermo Fisher Scientific's other — consolidated long-lived assets?
Thermo Fisher Scientific (TMO) reported other — consolidated long-lived assets of $5.47B in Q4 2025.
What does other — consolidated long-lived assets mean?
The total value of long-term assets held by business units or regions categorized as 'Other'.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.